CIK 0000318306
- Non-accelerated filer
- Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 830221517
- Phone
- +1 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $34,349
- in 1 filing
- Open-market sales, last 90 days
- $296,397
- in 5 filings
Net −$262,048. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-08 | O'Malley Brendan M. SVP, Chief Legal Officer | Sale | −4,826 | $5.43 | $26K | 446,308 |
| 2026-05-22 | Alvino Mark Director | Sale | −6,500 | $5.46 | $35K | 77,565 |
| 2026-05-15 | Crombez Eric Director | Sale 10b5-1 | −26,143 | $5.53 | $145K | 37,313 |
| 2026-05-11 | Vasanthavada Madhav Chief Commercial Officer | Sale | −5,548 | $5.96 | $33K | 313,071 |
| 2026-03-31 | Seshadri Vishwas Chief Executive Officer | Sale 10b5-1 | −29,985 | $4.38 | $131K | 1,430,423 |
| 2026-03-16 | Vazzano Joseph Walter Chief Financial Officer | Sale | −785 | $4.76 | $4K | 567,775 |
| 2026-02-02 | Silverstein Christine Berni Director | Sale | −20,070 | $5.09 | $102K | 137,722 |
| 2026-02-02 | Wuchterl Donald A. Director | Sale | −14,814 | $5.09 | $75K | 167,935 |
| 2026-02-02 | Crombez Eric Director | Sale | −16,284 | $5.09 | $83K | 63,456 |
| 2026-02-02 | Alland Leila Director | Sale | −18,065 | $5.09 | $92K | 173,614 |
| 2026-02-02 | Alvino Mark Director | Sale | −2,000 | $5.09 | $10K | 84,065 |
| 2026-01-22 | Vasanthavada Madhav Chief Commercial Officer | Sale | −12,610 | $5.29 | $67K | 318,619 |
| 2026-01-22 | Vazzano Joseph Walter Chief Financial Officer | Sale | −18,666 | $5.33 | $100K | 568,560 |
| 2026-01-22 | Seshadri Vishwas Chief Executive Officer | Sale | −69,832 | $5.33 | $372K | 1,460,408 |
| 2026-01-22 | O'Malley Brendan M. SVP, Chief Legal Officer | Sale | −13,578 | $5.33 | $72K | 451,134 |
| 2026-01-21 | Alvino Mark Director | Sale | −13,500 | $5.23 | $71K | 48,752 |
| 2025-12-29 | Seshadri Vishwas Chief Executive Officer | Sale 10b5-1 | −25,000 | $5.31 | $133K | 1,164,818 |
| 2025-11-13 | Alvino Mark Director | Sale | −15,000 | $4.74 | $71K | 62,252 |
| 2025-10-16 | Seshadri Vishwas Chief Executive Officer | Sale | −249 | $5.49 | $1K | 1,189,818 |
| 2025-09-30 | Seshadri Vishwas Chief Executive Officer | Sale 10b5-1 | −25,000 | $5.24 | $131K | 1,190,067 |
Page 2 of 7 · 136 trades